Seretide Diskos

Seretide, known as Advair in some markets, is a prominent pharmaceutical brand used for the management of asthma and chronic obstructive pulmonary disease (COPD). It is a combination medication containing salmeterol and fluticasone propionate. The brand was developed and brought to market by GlaxoSmithKline (GSK), a British multinational pharmaceutical company.

While GSK has a global manufacturing network, Seretide Diskos inhalers have historically been produced at key facilities in the United Kingdom, such as Ware, and in France (Evreux). However, production can vary based on regional supply chains and international distribution needs. The brand remains under the ultimate ownership of GSK, which continues to be headquartered in London, England. In many local markets, the product is distributed by GSK's regional subsidiaries, following strict healthcare regulations and licensing requirements specific to each country.